Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01936688
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Who this might be right for
Plaque-type Psoriasis
Sun Pharmaceutical Industries Limited
Large-scale testing (Phase 3)Study completedNCT01970488
What this trial is testing

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 350
Testing effectiveness (Phase 2)Study completedNCT04612699
What this trial is testing

Jaktinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
Moderate-to-Severe Plaque Psoriasis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 123
Large-scale testing (Phase 3)Study completedNCT03536884
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 743
Not applicableStudy completedNCT05811234
What this trial is testing

Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 291
Post-approval studies (Phase 4)Ended earlyNCT00697593
What this trial is testing

ChangE From Any Systemic psoriasiS therapY to Raptiva

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 70
Large-scale testing (Phase 3)Study completedNCT06586112
What this trial is testing

Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alumis Inc 912
Large-scale testing (Phase 3)Study completedNCT01646177
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,346
Not applicableStudy completedNCT02954081
What this trial is testing

APremilast After FumaRic Acid Ester Treatment

Who this might be right for
Psoriasis
Amgen 687
Large-scale testing (Phase 3)Looking for participantsNCT07250802
What this trial is testing

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 110
Large-scale testing (Phase 3)Study completedNCT00747344
What this trial is testing

Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 121
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07158268
What this trial is testing

HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 220
Large-scale testing (Phase 3)Study completedNCT01967069
What this trial is testing

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

Who this might be right for
Psoriasis
Primus Pharmaceuticals 277
Large-scale testing (Phase 3)Study completedNCT04036435
What this trial is testing

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 1,466
Large-scale testing (Phase 3)UnknownNCT06299982
What this trial is testing

An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO

Who this might be right for
Plaque Psoriasis Patients
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 750
Large-scale testing (Phase 3)Study completedNCT01206660
What this trial is testing

Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00725348
What this trial is testing

An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Stiefel, a GSK Company 19
Post-approval studies (Phase 4)Study completedNCT06329258
What this trial is testing

Combination of Sotyktu and Enstilar for Plaque Psoriasis

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 30
Large-scale testing (Phase 3)Study completedNCT02409667
What this trial is testing

Plaque Psoriasis Efficacy and Safety With Secukinumab

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 16,487
Testing effectiveness (Phase 2)Study completedNCT02888236
What this trial is testing

LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation